dc.contributorINSERM
dc.contributorFleury Inst
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.creatorReis, A. F.
dc.creatorHauache, O. M.
dc.creatorVelho, G.
dc.date.accessioned2016-01-24T12:38:02Z
dc.date.available2016-01-24T12:38:02Z
dc.date.created2016-01-24T12:38:02Z
dc.date.issued2005-09-01
dc.identifierDiabetes & Metabolism. Moulineaux Cedex 9: Masson Editeur, v. 31, n. 4, p. 318-325, 2005.
dc.identifier1262-3636
dc.identifierhttp://repositorio.unifesp.br/handle/11600/28453
dc.identifier10.1016/S1262-3636(07)70200-8
dc.identifierWOS:000232234100001
dc.description.abstractThe Vitamin D endocrine system regulates multiple aspects of calcium metabolism and cellular differentiation and replication in the immune system, endocrine pancreas, liver, skeletal muscles and adipocytes. It plays an important role in glucose homeostasis, notably, in the mechanism of insulin release. Actions of vitamin D are mediated by the binding of 1,25-(OH)2D3 to a specific cytosolic/nuclear vitamin D receptor (VDR), a member of the steroid/thyroid hormone receptor superfamily. Several frequent polymorphisms are found in the VDR gene and were reported to be associated with a variety of physiological and pathological phenotypes in many populations. in this paper, we will review the evidences suggesting associations of allelic variations in the VDR gene and phenotypes related to body weight, glucose homeostasis, diabetes and its vascular complications.
dc.languageeng
dc.publisherMasson Editeur
dc.relationDiabetes & Metabolism
dc.rightsAcesso restrito
dc.subjectvitamin D
dc.subjectvitamin D receptor (VDR)
dc.subjectvitamin D binding protein (DBP)
dc.subjecttype 1 diabetes
dc.subjecttype 2 diabetes
dc.subjectobesity
dc.subjectinsulin secretion
dc.subjectinsulin sensitivity
dc.subjectcardiovascular disease
dc.titleVitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence
dc.typeResenha


Este ítem pertenece a la siguiente institución